PALX — Palomino Laboratories Balance Sheet
0.000.00%
- $386.91m
- $367.47m
Annual balance sheet for Palomino Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 0.14 | 0.135 | 8.12 |
| Prepaid Expenses | |||
| Total Current Assets | 0.14 | 0.138 | 8.43 |
| Total Assets | 0.14 | 0.138 | 8.43 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.005 | 0.006 | 0.336 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 0.142 | 0.156 | 0.336 |
| Non Redeemable Preferred Stock | |||
| Common Stock | |||
| Additional Paid In Capital | |||
| Other Equity | |||
| Total Equity | -0.002 | -0.018 | 8.1 |
| Total Liabilities & Shareholders' Equity | 0.14 | 0.138 | 8.43 |
| Total Common Shares Outstanding |